Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
19
NCT02820350
Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).
Phase: N/A
Role: Lead Sponsor
Start: Dec 4, 2016
Completion: Mar 31, 2020